Mao Ye Selected Research

Cognitive Dysfunction

1/2023	Reducing complement activation during sleep deprivation yields cognitive improvement by dexmedetomidine.
4/2022	Involvement of Paired Immunoglobulin-like Receptor B in Diabetes-Associated Cognitive Dysfunction Through Modulation of Axon Outgrowth and Dendritic Remodeling.
12/2019	Phenylalanine Monitoring via Aptamer-Field-Effect Transistor Sensors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mao Ye Research Topics

Disease

64	Neoplasms (Cancer) 04/2024 - 12/2004
10	Multiple Myeloma 01/2023 - 11/2012
7	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
5	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2011
5	Melanoma (Melanoma, Malignant) 01/2022 - 02/2008
4	Inflammation (Inflammations) 01/2023 - 10/2019
4	Leukemia 11/2012 - 12/2004
4	Nasopharyngeal Carcinoma 01/2011 - 12/2004
3	Pain (Aches) 01/2023 - 01/2021
3	Cognitive Dysfunction 01/2023 - 12/2019
3	Postoperative Pain 01/2023 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2019
3	Hematoma 01/2023 - 04/2012
3	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2020
3	Uveal melanoma 01/2023 - 02/2008
3	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 11/2015
3	Infections 01/2022 - 04/2012
3	COVID-19 01/2021 - 01/2020
3	Congenital Heart Defects (Congenital Heart Defect) 04/2020 - 10/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 10/2019
3	Insulin Resistance 01/2017 - 01/2015
2	Bites and Stings (Sting) 04/2024 - 01/2022
2	Adenocarcinoma 04/2024 - 01/2015
2	Ulcerative Colitis 01/2024 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2023
2	Chromosomal Instability (Chromosome Stability) 09/2023 - 09/2005
2	Thyroid Neoplasms (Thyroid Cancer) 03/2021 - 09/2016
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 06/2016 - 05/2007
2	Necrosis 04/2015 - 03/2007
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2023
1	Milk Hypersensitivity (Milk Allergy) 09/2023

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2005
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2012
6	LigandsIBA 12/2023 - 02/2008
6	lycorineIBA 01/2020 - 12/2004
5	A-Form DNA (A-DNA)IBA 12/2022 - 09/2018
5	Nucleic AcidsIBA 12/2022 - 11/2012
4	Nucleotide AptamersIBA 01/2023 - 01/2012
4	UbiquitinIBA 01/2022 - 01/2015
4	Bortezomib (Velcade)FDA Link 01/2022 - 01/2016
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
4	Cadherins (E-Cadherin)IBA 11/2021 - 02/2008
4	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014 - 12/2004
3	B7-H1 AntigenIBA 04/2024 - 01/2022
3	LipidsIBA 01/2023 - 01/2018
3	Albendazole (Albenza)FDA Link 01/2022 - 11/2021
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2017
3	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2016
3	OligonucleotidesIBA 01/2018 - 01/2015
3	grifolinIBA 01/2011 - 06/2005
2	InterferonsIBA 04/2024 - 01/2022
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2023 - 01/2021
2	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 01/2021
2	C-Reactive ProteinIBA 01/2023 - 01/2021
2	BilirubinIBA 01/2023 - 07/2020
2	Dexmedetomidine FDA Link 01/2023 - 04/2020
2	AlbuminsIBA 01/2023 - 01/2018
2	AcidsIBA 12/2022 - 09/2008
2	NucleolinIBA 12/2022 - 07/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2007
2	CytokinesIBA 01/2022 - 01/2020
2	Antiparasitic Agents (Antiparasitics)IBA 01/2022 - 11/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2017
2	NF-kappa B (NF-kB)IBA 11/2021 - 09/2005
2	Deubiquitinating EnzymesIBA 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2020 - 07/2020
2	Alanine Transaminase (SGPT)IBA 11/2020 - 07/2020
2	CateninsIBA 01/2020 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019 - 01/2015
2	ProdrugsIBA 05/2019 - 11/2015
2	Orphan Nuclear ReceptorsIBA 12/2018 - 09/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2018 - 02/2008
2	VimentinIBA 01/2017 - 12/2016
2	CurcuminIBA 01/2017 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 04/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 01/2015
2	AlkaloidsIBA 04/2015 - 12/2004
2	Catalytic DNA (Deoxyribozyme)IBA 04/2013 - 07/2005
2	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2013 - 09/2005
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2009 - 05/2007
2	4- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA 09/2008 - 05/2007
2	RetinoidsIBA 09/2008 - 05/2007
1	tongxie-yaofangIBA 01/2024
1	Therapeutic UsesIBA 12/2023
1	SeleniumIBA 10/2023
1	NAD (NADH)IBA 10/2023
1	alkaline proteaseIBA 09/2023
1	Cell-Free Nucleic AcidsIBA 09/2023

Therapy/Procedure

24	Therapeutics 01/2023 - 10/2009
8	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
4	Immunotherapy 04/2024 - 01/2022
4	Hepatectomy 01/2023 - 01/2021
3	Punctures 01/2023 - 04/2012
3	Precision Medicine 11/2021 - 01/2015
3	Sutures (Suture) 02/2020 - 01/2014
2	Liver Transplantation 11/2021 - 12/2013
2	Intravenous Injections 01/2018 - 01/2014